Suchergebnisse - "Esfahani, Ensieh Nasli"

PubPharm (62)

31

Conceptual map of diabetes education: necessity of establishing iran diabetes academy

enthalten in: Journal of diabetes & metabolic disorders | 2019

von Sanjari, M. | Aalaa, M. | Amini, M. | +4

32

Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents : In vitro α-glucosidase inhibition, kinetic, and docking study

enthalten in: Bioorganic chemistry | 2019

von Saeedi, M. | Mohammadi-Khanaposhtani, M. | Pourrabia, P. | +11

33

Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents : In vitro α-glucosidase inhibition, kinetic, and in silico studies

enthalten in: Bioorganic & medicinal chemistry letters | 2019

von Adib, M. | Peytam, F. | Shourgeshty, R. | +9

34

Biology-Oriented Drug Synthesis (BIODS) Approach towards Synthesis of Ciprofloxacin-Dithiocarbamate Hybrids and Their Antibacterial Potential both in Vitro and in Silico

enthalten in: Chemistry & biodiversity | 2018

von Esfahani, E. | Mohammadi-Khanaposhtani, M. | Rezaei, Z. | +9

35

New ciprofloxacin–dithiocarbamate–benzyl hybrids: design, synthesis, antibacterial evaluation, and molecular modeling studies

enthalten in: Research on chemical intermediates | 2018

von Esfahani, E. | Mohammadi-Khanaposhtani, M. | Rezaei, Z. | +9

36

New ciprofloxacin–dithiocarbamate–benzyl hybrids: design, synthesis, antibacterial evaluation, and molecular modeling studies

enthalten in: Research on chemical intermediates | 2018

von Esfahani, E. | Mohammadi-Khanaposhtani, M. | Rezaei, Z. | +9

37

New ciprofloxacin–dithiocarbamate–benzyl hybrids: design, synthesis, antibacterial evaluation, and molecular modeling studies

enthalten in: Research on chemical intermediates | 2018

von Esfahani, E. | Mohammadi-Khanaposhtani, M. | Rezaei, Z. | +9

38

Reply to Letter to the Editor "The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes : a randomized, double-blind, placebo-controlled clinical trial"

enthalten in: Acta diabetologica | 2018

von Seyyedebrahimi, S. | Khodabandehloo, H. | Esfahani, E. | +1

CommentOn: Acta Diabetol. 2018 Apr;55(4):341-353. - PMID 29357033

39

Resveratrol supplementation decreases blood glucose without changing the circulating CD14+CD16+ monocytes and inflammatory cytokines in patients with type 2 diabetes : a randomized, double-blind, placebo-controlled study

enthalten in: Nutrition research (New York, N.Y.) | 2018

von Khodabandehloo, H. | Seyyedebrahimi, S. | Esfahani, E. | +2

40

Reply to Letter to the Editor “The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial”

enthalten in: Acta diabetologica | 2018

von Seyyedebrahimi, S. | Khodabandehloo, H. | Esfahani, E. | +1